Shionogi to Partner with ALS/MND Natural History Consortium to Collect Real-World Data in ALS, Reinforcing Investments in ALS Research
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter, “Shionogi”) today announced its continued partnership with the ALS/MND Natural History Consortium (Consortium) to collect real-world data in amyotrophic lateral sclerosis (ALS).
